Feasibility Analysis for Treatment of Giant Intracranial Benign Tumor by Delayed Operation in Infancy

World Neurosurg. 2017 Mar:99:122-131. doi: 10.1016/j.wneu.2016.11.140. Epub 2016 Dec 6.

Abstract

Objective: The survival rate and prognosis in infants with giant intracranial tumors are significantly worse than in older children. This study aimed to analyze the feasibility of delayed operation for infants with giant intracranial benign tumor by evaluating the initial clinical presentations, expectant treatment measures, perioperative vital signs, and recuperation after surgery.

Patients and data: We reviewed 3 infant patients (average age, 9.33 months; range, 5-12 months) with giant intracranial benign tumors during January 2015 and April 2016. The maximum sections of tumors were 38 × 50 mm, 57 × 39 mm, and 55 × 67 mm, respectively. All clinical presentations, neuroimaging, and laboratory examinations were recorded.

Results: Obstructive hydrocephalus was observed in 2 infants; ventriculoperitoneal shunts were placed in both before the delayed tumor resection. The disease progressed rapidly in the infant with teratoma and surgery was performed 4 months after placement of the ventriculoperitoneal shunt. The other 2 patients had experienced a 12-month growth and developmental phase and later underwent operations. Gross total resection was achieved in all patients. The pathologic results were consistent with the preoperative diagnosis. During a period of high-quality postoperative care, they remained stable and were discharged without any complications or neurologic deficits, and continued to improve toward their baseline.

Conclusions: Delayed operation enabled infant patients to gain a better physical state, with a stage of full preoperative preparation that may reduce intraoperative/postoperative morbidity and mortality.

Keywords: Delayed operation; Giant benign brain tumors; Growth and developmental phase; Infant craniotomy.

Publication types

  • Case Reports

MeSH terms

  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / surgery*
  • Female
  • Humans
  • Hydrocephalus
  • Infant
  • Male
  • Time-to-Treatment*
  • Treatment Outcome